Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

104.84% (1Y)

Market Cap	18.54B
Revenue (ttm)	1.98B
Net Income (ttm)	387.42M
Shares Out	733.37M
EPS (ttm)	0.51
PE Ratio	51.84
Forward PE	54.79
Dividend	0.03 (0.11%)
Ex-Dividend Date	Jul 31, 2024

Volume	35,284,528
Average Volume	32,477,059
Open	26.02
Previous Close	26.52
Day's Range	25.72 - 26.52
52-Week Range	12.38 - 26.90
Beta	0.72
RSI	82.25
Earnings Date	Aug 27, 2025

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 2,652
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603127

Financial Performance

In 2024, SHA:603127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.